l & e x perimenta l i n ic lp journal of clinical ... · clinicopathological prognostic factors...

3
An Unsual Case of Eyelid Leiomyosarcoma and Orbital Invasion with MRI Findings Edgard Farah 1* , Pierre-Vincent Jacomet 1 , Mathieu Zmuda 1 , Marc Putterman 2 and Olivier Galatoire 1 1 Oculoplastic department, Fondation Ophtalmologique Adolphe de Rothschild, Ophtalmology, France 2 Consultant, France * Corresponding author: Edgard Farah, Fellow in Oculoplastic department, Fondation Ophtalmologique Adolphe de Rothschild, Ophtalmology, Paris -75019, France; Tel: +33619354503; E-mail: [email protected] Received date: Dec 02, 2014, Accepted date: Jan 20, 2015, Published date: Jan 23, 2015 Copyright: © 2015 Farah, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Abstract A 73 years old woman presented with 10 months history of inferior eyelid nodule, the biopsy revealed at the time a grade 2 leiomyosarcoma without metastasis, the excision was considered inappropriate and radiotherapy was performed. The patient was addressed for resistant ocular pain management grade 3 and persistence of the lesion despite all the treatments. The mass is now measuring 8 cm in maximal diameter. The MRI showed lesions that affect mainly the median extra orbital part. An embolization of the main artery that vascularise the lesion was performed, proceeded by wide exenteration. The patient died 4 months later of local recurrence in the orbital cavity and metastases. Leiomyosarcoma as a highly malignant character showed a furious resistance to chemotherapy, radiotherapy and embolization so wide radical exenteration from the beginning might give better chance at long term survival. Keywords: Leiomyosarcoma; Orbit; Radiotherapy; Exenteration Case Report A 73 years old woman presented with 10 months history of inferior eyelid nodule without ocular symptoms, the histology of the biopsy revealed at the time a grade 2 leiomyosarcoma without metastasis. A multidisciplinary approach made by her surgeon, oncologist and radiologist recommended a radiotherapy with adjuvant chemotherapy as an initial therapy. The radiotherapy was performed with a dose of 30 Gy in 10 fractions 3 Gy per session during 3 months. An adjuvant treatment with chemotherapy 6 cycles (75mg/m2/cycle) was performed in interval of 3 months. The patient was addressed 3 months later to our department for resistant ocular pain management grade 3 and persistence of the lesion despite all the treatments. The mass is now measuring 8 cm in maximal diameter (Figure 1), the MRI showed a lesion that affect mainly the median extra orbital and extraconal part without infiltration of the intraconal fat nor the optic nerve (Figure 3 ), in the cerebral arteriography we can visualize the vascularisation of the lesion by the external carotid (terminal branches of infernal Maxillary artery) and the ipsilateral ophthalmic artery [1,2]. An embolisation of the main artery that vascularise the lesion was performed, proceeded by wide exenteration without adjunctive radiotherapy due to rapid clinical deterioration of the patient. The diagnosis of leimyosarcoma is confirmed by histopathalogic examination that revealed grade 2 by clinical grade (Figure 2) cellularity +++, spindle shaped cells that have cigar-shaped nuclei, mitotic index 15 (x10), Necrosis (0) and high grade cellular atypia, and grade 3 of malignancy by AJCC staging system that was confirmed by the high histological grade and the tumor size (≥ 5 cm) [3,4]. Figure 1: Multi-lobulated, well vascularised mass measuring 8 cm on maximal diameter. Farah et al., J Clin Exp Ophthalmol 2015, 6:1 DOI: 10.4172/2155-9570.1000388 Case Report Open Access J Clin Exp Ophthalmol ISSN:2155-9570 JCEO an open access journal Volume 6 • Issue 1 • 1000388 Journal of Clinical & Experimental Ophthalmology J o ur n a l o f C l i n ic a l & E x pe r i m e n t a l O p h t h a l m o lo g y ISSN: 2155-9570

Upload: others

Post on 24-Jun-2020

2 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: l & E x perimenta l i n ic lp Journal of Clinical ... · Clinicopathological prognostic factors in soft tissue Leiomyosarcoma : a multivariate analysis Histopathology 40: 353-359

An Unsual Case of Eyelid Leiomyosarcoma and Orbital Invasion with MRIFindingsEdgard Farah1*, Pierre-Vincent Jacomet1, Mathieu Zmuda1, Marc Putterman2 and Olivier Galatoire1

1Oculoplastic department, Fondation Ophtalmologique Adolphe de Rothschild, Ophtalmology, France2Consultant, France*Corresponding author: Edgard Farah, Fellow in Oculoplastic department, Fondation Ophtalmologique Adolphe de Rothschild, Ophtalmology, Paris -75019, France;Tel: +33619354503; E-mail: [email protected]

Received date: Dec 02, 2014, Accepted date: Jan 20, 2015, Published date: Jan 23, 2015

Copyright: © 2015 Farah, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use,distribution, and reproduction in any medium, provided the original author and source are credited.

Abstract

A 73 years old woman presented with 10 months history of inferior eyelid nodule, the biopsy revealed at the timea grade 2 leiomyosarcoma without metastasis, the excision was considered inappropriate and radiotherapy wasperformed. The patient was addressed for resistant ocular pain management grade 3 and persistence of the lesiondespite all the treatments. The mass is now measuring 8 cm in maximal diameter. The MRI showed lesions thataffect mainly the median extra orbital part. An embolization of the main artery that vascularise the lesion wasperformed, proceeded by wide exenteration. The patient died 4 months later of local recurrence in the orbital cavityand metastases. Leiomyosarcoma as a highly malignant character showed a furious resistance to chemotherapy,radiotherapy and embolization so wide radical exenteration from the beginning might give better chance at long termsurvival.

Keywords: Leiomyosarcoma; Orbit; Radiotherapy; Exenteration

Case ReportA 73 years old woman presented with 10 months history of inferior

eyelid nodule without ocular symptoms, the histology of the biopsyrevealed at the time a grade 2 leiomyosarcoma without metastasis. Amultidisciplinary approach made by her surgeon, oncologist andradiologist recommended a radiotherapy with adjuvant chemotherapyas an initial therapy. The radiotherapy was performed with a dose of30 Gy in 10 fractions 3 Gy per session during 3 months. An adjuvanttreatment with chemotherapy 6 cycles (75mg/m2/cycle) wasperformed in interval of 3 months. The patient was addressed 3months later to our department for resistant ocular pain managementgrade 3 and persistence of the lesion despite all the treatments. Themass is now measuring 8 cm in maximal diameter (Figure 1), the MRIshowed a lesion that affect mainly the median extra orbital andextraconal part without infiltration of the intraconal fat nor the opticnerve (Figure 3 ), in the cerebral arteriography we can visualize thevascularisation of the lesion by the external carotid (terminal branchesof infernal Maxillary artery) and the ipsilateral ophthalmic artery [1,2].

An embolisation of the main artery that vascularise the lesion wasperformed, proceeded by wide exenteration without adjunctiveradiotherapy due to rapid clinical deterioration of the patient.

The diagnosis of leimyosarcoma is confirmed by histopathalogicexamination that revealed grade 2 by clinical grade (Figure 2)cellularity +++, spindle shaped cells that have cigar-shaped nuclei,mitotic index 15 (x10), Necrosis (0) and high grade cellular atypia, andgrade 3 of malignancy by AJCC staging system that was confirmed bythe high histological grade and the tumor size (≥ 5 cm) [3,4].

Figure 1: Multi-lobulated, well vascularised mass measuring 8 cmon maximal diameter.

Farah et al., J Clin Exp Ophthalmol 2015, 6:1 DOI: 10.4172/2155-9570.1000388

Case Report Open Access

J Clin Exp OphthalmolISSN:2155-9570 JCEO an open access journal

Volume 6 • Issue 1 • 1000388

Journal of Clinical & Experimental OphthalmologyJo

urna

l of C

linica

l & Experimental Ophthalmology

ISSN: 2155-9570

Page 2: l & E x perimenta l i n ic lp Journal of Clinical ... · Clinicopathological prognostic factors in soft tissue Leiomyosarcoma : a multivariate analysis Histopathology 40: 353-359

Figure 2: Histopathology images of High grade leiomyosarcoma fig a (x 10), fig b (x20), tumor showing spindle-shaped neoplastic infiltration.

Figure 3: MRI shows a left orbital mass (left) transaxial T1 weighted MRI image demonstrates an 8 cm mass that is hypointense relative tocerebral cortex with peripheral contrast enhancement. (Right) transaxial T2-weighted MRI the mass is isointense relative to cerebral cortex.

Immunohistochemistry test showed that the tumor cells werepositive for antismooth muscle actin, CD68 and negative for s-100proteine, CD 30, desmine, caldesmone.

According to Myajima et al. the tumor size and AJCC stage inleiomyosarcoma are the most reliable prognostic parameters forsurvival rate [5]. The patient died 4 months later of local recurrence inthe orbital cavity and metastases in the near ganglions, lungs and liver.

DiscussionLeiomyosarcoma is a rare neoplasm of smooth muscle, a primary

myogenic tumor in the orbit is suspected to be vascular smooth muscle[3]. Folberg et al. described orbital leiomyosarcoma secondary toradiation for bilateral retinoblastoma [6]. Hou et al. suggested thatMRI can provide more important information then CT andUltrasound [1], on T1 weighted MRI the tumor was hypointense andon T2 it was Isonintense relatively to cerebral cortex with peripheralcontrast enhancement and extraconal location of the mass (Figure 3).

In the literature the surgical wide local resection was the treatmentof choice, Jakobiec et al. recommend exenteration with the removal ofany involved bone required because of the high infiltrative nature ofleiomyosarcoma [4] and it is possible that asymptomatic metastasesmay have occurred before exenteration so a meticulous search for anymetastasis especially lung metastasis should be conducted before anytreatment.

Our case illustrate, that leiomyosarcoma as a highly malignantcharacter showed a furious resistance to chemotherapy, radiotherapyand embolization so wide radical exenteration with adjunctiveradiotherapy from the beginning might give better chance at long termsurvival.

References1. Hou LC, Murphy MA, Tung GA (2013) Primary Orbital

Leiomyosarcoma : A Case Report With MRI Findings. American J ofOphtalmol 408-410.

Citation: Farah E, Jacomet PV, Zmuda MV, Putterman M, Galatoire O (2015) An Unsual Case of Eyelid Leiomyosarcoma and Orbital Invasionwith MRI Findings . J Clin Exp Ophthalmol 6: 388. doi:10.4172/2155-9570.1000388

Page 2 of 3

J Clin Exp OphthalmolISSN:2155-9570 JCEO an open access journal

Volume 6 • Issue 1 • 1000388

Page 3: l & E x perimenta l i n ic lp Journal of Clinical ... · Clinicopathological prognostic factors in soft tissue Leiomyosarcoma : a multivariate analysis Histopathology 40: 353-359

2. Yeniad B, Tuncer S, Gonul P, Ozgur M, Ozenc M, et al. (2009) PrimaryOrbital Leiomyosarcoma American Society of Ophtalmic Plastic AndReconstructive Surgery 154-155.

3. I-Chan lin, Chen-Tu Wu (2005) Primary Orbital Leiomyosarcoma.Ophtalmic Plastic And Reconstructive Surgery 451-453.

4. Ted Jakobiec FA, Howard GM, Rosen M, Wolff M (1975) Leiomyomaand leiomyosarcoma of the orbit. Am J Ophtalmol 80: 1028-1042.

5. Miyajima K, Oda Y, Oshiro Y, Tamiya S, Kinukawa N, et al. (2001)Clinicopathological prognostic factors in soft tissue Leiomyosarcoma : amultivariate analysis Histopathology 40: 353-359.

6. Folberg R, Cleasby G, Flanagan JA, Spencer WH, Zimmerman LE (1983)Orbital Leiomyosarcoma After Radiation Therapy for BilateralRetinoblastoma. Arch Ophthalmol 101: 1562-1565.

Citation: Farah E, Jacomet PV, Zmuda MV, Putterman M, Galatoire O (2015) An Unsual Case of Eyelid Leiomyosarcoma and Orbital Invasionwith MRI Findings . J Clin Exp Ophthalmol 6: 388. doi:10.4172/2155-9570.1000388

Page 3 of 3

J Clin Exp OphthalmolISSN:2155-9570 JCEO an open access journal

Volume 6 • Issue 1 • 1000388